- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
B
BVS
Bioventus Inc.
8.58
0.000.00%After Hours: 8.63 +0.05 +0.58%17:07 02/20 EST
OPEN/PREV CLOSE8.57/8.58
TODAY RANGE8.37-8.64
VOL204.69K
MARKET CAP710.11M
52 WEEK RANGE5.81-11.25
AVG VOL (3M)265.94K
% TURNOVER0.25%
TURNOVER--
P/E (TTM)76.40
% RANGE3.15%
EPS(TTM)0.1123
P/E(FORWARD)33.00
P/B4.275
BVPS2.007
DIVIDEND--
P/S1.220
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP506.40M
SHARES OUTSTANDING82.76M
NEXT EARNINGS03/09-03/13
FREE FLOAT59.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·02/09 13:11
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
TipRanks·02/09 13:00
Bioventus initiated with an Outperform at Barrington
TipRanks·02/09 12:55
Bioventus (BVS) Has a New Rating from Barrington
Dow Jones·02/09 12:47
Bioventus Initiated at Outperform by Barrington Research
Dow Jones·02/09 12:47
Bioventus Price Target Announced at $13.00/Share by Barrington Research
Simply Wall St·01/10 13:57
Recent uptick might appease Bioventus Inc. (NASDAQ:BVS) institutional owners after losing 13% over the past year
TipRanks·12/17/2025 12:09
Bioventus (BVS) Receives a Buy from Canaccord Genuity
TipRanks·12/09/2025 02:09
Director Sells Thousands of Bioventus Shares in Lucrative Deal
Reuters·12/03/2025 15:17
Bioventus Inc. highlights market leadership and growth strategy in healthcare presentation
Seeking Alpha·12/02/2025 17:02
Bioventus: A New Start
Simply Wall St·11/26/2025 10:25
Bioventus (NASDAQ:BVS) Seems To Use Debt Quite Sensibly
Reuters·11/25/2025 23:06
Bioventus Inc. Files Initial Beneficial Ownership Statement for Director Ajay Dhankhar
Same Industry
Name/Symbol
Change%
Price